Latest Updates
|
January 2010 New Drug Updates and
Additions
|
Designation
|
Brand Name
|
Generic Name
|
|
ACE-041
|
|
|
ACTB1003 |
|
|
ACTB1010 |
|
|
ACTB1011 |
|
|
ADXS11-001, Lm-LLO-E7 |
Lovaxin C |
|
ANX-530, formerly SDP-012 |
|
Vinorelbine tartrate |
ANX-514, formerly SDP-014 |
|
|
D-63153, SPI-153 |
|
Ozarelix |
|
|
Talactoferrin alfa, talactoferrin |
ALXN6000 |
|
|
E75 |
NeuVax |
|
EG009, ad.HSV tk |
Cerepro |
|
AZD6244, ARRY-142886, ARRY-886 |
|
|
ATI-1123-Docetaxel |
|
|
L19-IL2 |
|
|
BCX-1777 |
Fodosine |
Forodesine hydrochloride |
BI-505 |
|
|
Mycobacterial Cell Wall-DNA Complex (MCC), MCC/HA |
Urocidin |
|
BNP1350 |
|
Karenitecin |
|
BiovaxID |
|
|
Multikine |
Leukocyte interleukin injection |
CR011, CR011-vcMMAE |
|
Glembatumumab vedotin |
CP-4126 |
|
Gemcitabine 5'-elaidic acid ester |
DOXO-EMCH, INNO-206 |
|
|
CUDC-305, CUDC-0305, Debio 0932. |
|
|
ENMD-981693, ENMD-2076 |
|
|
PEG-SN38, EZN-2208 |
|
|
|
Graspa |
|
Cur-691, GDC-0449, RG3616 |
HhAntag |
|
G-202 |
|
|
XL880, XL-880, GSK1363089, GSK089 |
|
Foretinib |
GSK2118436 |
|
|
GA101, RO5072759, RG7159 |
GlycoMAb |
|
IMC-1121b, IMC 1121B (previously IMC-1CIIb, IMC-2C6, c-P1C11, IMC-1C11, DC101) |
|
Ramucirumab |
IMC-11F8 |
|
Necitumumab |
IMC-3G3 |
|
|
IMC-EB10 |
|
|
IMMU-103, hLL2, hCD22, AMG 412 |
LymphoCide |
Epratuzumab |
IMMU-106, hA20, hCD20 |
|
Veltuzumab |
IPI-926 |
|
|
INK128 |
|
|
IRX-2 |
|
Citoplurikin |
KB004 |
|
|
MB7133, MB07133 |
|
|
LOR-253, ML-220, ML-series (ML-133 and LT-253) |
|
|
G207 |
|
|
MK2206, MK-2206 |
|
|
HYB2055, IMO-2055, EMD 1201081 |
IMOxine |
|
DI-B4 |
|
|
MGN1601 |
|
|
LEP-ETU (formerly PNU-93914) |
|
Paclitaxel |
Liposome Entrapped Docetaxel for Injection (LE-DT) |
|
Docetaxel |
NS-187, INNO-406, CNS-9 |
|
Bafetinib |
DMXAA, AS1404, AS-1404, ASA404 |
|
Vadimezan |
AVR118, AVR 118, OHR118 |
Formerly Product R or Reticulose |
|
SC-1 |
|
|
PAT-LM1, LM-1 |
|
|
PAT-SM6, SAM-6 |
|
|
PAT-CM1, CM-1, NM1, PM1 |
|
|
CP-751871, CP-751,871 |
|
Figitumumab |
RX-3117 |
|
|
PLX4032, PLX4720, RG7204, RO5185426 |
|
|
HuM195, SMART M195, SGN-33 |
Zamyl |
Lintuzumab |
SNS-595, SPC-595 (formerly AG-7352) |
|
Voreloxin |
TAP1, AdhTAP, AdhTAP(OS-1) |
|
|
TL32711 |
|
|
TLN-4601, ECO-04601, ECO-4601, MW 462 |
|
|
TH-302, HAP-302 |
|
|
VNP40101M, 101M |
Onrigin (formerly Cloretazine) |
Laromustine |
VM206 |
|
|
ZIO-201, ZIO-201-T |
Zymafos |
Palifosfamide, isophosphoramide mustard |
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|